Abstract |
Using proteomics, we identified nucleoside diphosphate kinase A (NDPKA; also known as NME/NM23 nucleoside diphosphate kinase 1: NME1) to be up-regulated in primary cortical neuronal cultures by erythropoietin (EPO) preconditioning. To investigate a neuroprotective role of NDPKA in neurons, we used a RNAi construct to knock-down and an adenoviral vector to overexpress the protein in cortical neuronal cultures prior to exposure to three ischemia-related injury models; excitotoxicity ( L-glutamic acid), oxidative stress ( hydrogen peroxide), and in vitro ischemia ( oxygen- glucose deprivation). NDPKA down-regulation had no effect on neuronal viability following injury. By contrast, NDPKA up-regulation increased neuronal survival in all three-injury models. Similarly, treatment with NDPKA recombinant protein increased neuronal survival, but only against in vitro ischemia and excitotoxicity. These findings indicate that the NDPKA protein may confer a neuroprotective advantage following injury. Furthermore, as exogenous NDPKA protein was neuroprotective, it suggests that a cell surface receptor may be activated by NDPKA leading to a protective cell-signaling response. Taken together both NDPKAs intracellular and extracellular neuroprotective actions suggest that the protein is a legitimate therapeutic target for the design of drugs to limit neuronal death following stroke and other forms of brain injury.
|
Authors | Jonathan Teoh, Sherif Boulos, Joanne Chieng, Neville W Knuckey, Bruno P Meloni |
Journal | Cellular and molecular neurobiology
(Cell Mol Neurobiol)
Vol. 34
Issue 3
Pg. 379-92
(Apr 2014)
ISSN: 1573-6830 [Electronic] United States |
PMID | 24395206
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Neuroprotective Agents
- Erythropoietin
- Nucleoside-Diphosphate Kinase
- nucleoside diphosphate kinase, rat
|
Topics |
- Animals
- Brain Ischemia
(metabolism, prevention & control)
- Cell Survival
(drug effects, physiology)
- Cells, Cultured
- Cerebral Cortex
(drug effects, metabolism)
- Erythropoietin
(pharmacology, therapeutic use)
- Gene Expression Regulation
- HEK293 Cells
- Humans
- Neurons
(drug effects, metabolism)
- Neuroprotective Agents
(pharmacology, therapeutic use)
- Nucleoside-Diphosphate Kinase
(biosynthesis, pharmacology, therapeutic use)
- Rats
- Rats, Sprague-Dawley
- Up-Regulation
(drug effects, physiology)
|